<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2025-099</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9271</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL OBSERVATION</subject></subj-group></article-categories><title-group><article-title>Результаты лечения двух пациентов с MALT-лимфомой</article-title><trans-title-group xml:lang="en"><trans-title>Results of treatment of two patients with MALT lymphoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8590-2350</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тонеев</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Toneev</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тонеев Евгений Александрович, к.м.н., врач – торакальный хирург хирургического отделения торакальной онкологии, Областной клинический онкологический диспансер; доцент кафедры факультетской хирургии, Ульяновский государственный университет</p><p>432017, Ульяновск, ул. 12 Сентября, д. 90; 432017, Ульяновск, ул. Льва Толстого, д. 42</p></bio><bio xml:lang="en"><p>Evgeny A. Toneev, Cand. Sci. (Med.), Thoracic Surgeon of the Surgical Department of Thoracic Oncology, Regional Clinical Oncology Center; Associate Professor of the Faculty Surgery Department, Ulyanovsk State University</p><p>90, 12 Sentyabrya St., Ulyanovsk, 432017;  42, Lev Tolstoy St., Ulyanovsk, 432017</p></bio><email xlink:type="simple">e.toneev@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3567-8504</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чигирёва</surname><given-names>И. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Chigireva</surname><given-names>I. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чигирёва Инна Борисовна, к.м.н., главный врач</p><p>432071, Ульяновск, ул. Гагарина, д. 20</p><p> </p></bio><bio xml:lang="en"><p>Inna B. Chigireva, Cand. Sci. (Med.), Chief-Physician</p><p>20, Gagarin St., Ulyanovsk, 432071</p></bio><email xlink:type="simple">chigirevaib@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-0218-666X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шагдалеев</surname><given-names>Р. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Shagdaleev</surname><given-names>R. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шагдалеев Роман Фатыхович, ординатор кафедры госпитальной хирургии, анестезиологии, реаниматологии, урологии, травматологии и ортопедии, факультет стоматологии, фармации и последипломного медицинского образования</p><p>432017, Ульяновск, ул. Льва Толстого, д. 42</p></bio><bio xml:lang="en"><p>Roman F. Shagdaleev, Resident of the Department of Hospital Surgery, Anesthesiology, Intensive Care, Urology, Traumatology, and Orthopedics, Faculty of Dentistry, Pharmacy, and Postgraduate Medical Education, Institute of Medicine, Ecology, and Physical Education</p><p>42, Lev Tolstoy St., Ulyanovsk, 432017</p></bio><email xlink:type="simple">roman2000shagdaleev@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2551-9795</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фирстов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Firstov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фирстов Артемий Алексеевич, ординатор кафедры госпитальной хирургии, анестезиологии, реаниматологии, урологии, травматологии и ортопедии, факультет стоматологии, фармации и последипломного медицинского образования</p><p>432017, Ульяновск, ул. Льва Толстого, д. 42</p></bio><bio xml:lang="en"><p>Artemiy A. Firstov, Resident of the Department of Hospital Surgery, Anesthesiology, Resuscitation, Urology, Traumatology and Orthopedics, Faculty of Dentistry, Pharmacy, and Postgraduate Medical Education, Institute of Medicine</p><p>42, Lev Tolstoy St., Ulyanovsk, 432017</p></bio><email xlink:type="simple">firstart17081999@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-7031-9822</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Уренева</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ureneva</surname><given-names>R. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Уренева Регина Валерьевна, врач-патологоанатом патологоанатомического отделения, Областной клинический онкологический диспансер; преподаватель кафедры общей и клинической морфологии, медицинский факультет имени Т.З. Биктимирова, Ульяновский государственный университет</p><p>432017, Ульяновск, ул. 12 Сентября, д. 90; 432017, Ульяновск, ул. Льва Толстого, д. 42</p></bio><bio xml:lang="en"><p>Regina V. Ureneva, Pathologist of the Pathological Department, Regional Clinical Oncology Center; Assistant Lecturer of the General and Clinical Morphology Department, Ulyanovsk State University</p><p>90, 12 Sentyabrya St., Ulyanovsk, 432017;  42, Lev Tolstoy St., Ulyanovsk, 432017</p></bio><email xlink:type="simple">urenevarv@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-9695-1238</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлов</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlov</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Павлов Максим Олегович, студент, медицинский факультет, Институт медицины, экологии и физической культуры</p><p>432017, Ульяновск, ул. Льва Толстого, д. 42</p></bio><bio xml:lang="en"><p>Maksim O. Pavlov, Student Institute of Medicine, Ecology and Physical Culture</p><p>42, Lev Tolstoy St., Ulyanovsk, 432017</p></bio><email xlink:type="simple">avlovmaksim676@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-2858-2688</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мартынова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Martynova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мартынова Екатерина Вячеславовна, студентка, медицинский факультет, Институт медицины, экологии и физической культуры</p><p>432017, Ульяновск, ул. Льва Толстого, д. 42</p></bio><bio xml:lang="en"><p>Ekaterina V. Martynova, Student of Institute of Medicine, Ecology and Physical Culture</p><p>42, Lev Tolstoy St., Ulyanovsk, 432017</p></bio><email xlink:type="simple">katun4ik0075@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Областной клинический онкологический диспансер; &#13;
Ульяновский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Clinical Oncology Center; &#13;
Ulyanovsk State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Городская поликлиника № 1 имени С.М. Кирова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City Clinic №1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Ульяновский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ulyanovsk State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Областной клинический онкологический диспансер; &#13;
Ульяновский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Clinical Oncology Center; Ulyanovsk State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>30</day><month>07</month><year>2025</year></pub-date><volume>0</volume><issue>10</issue><fpage>170</fpage><lpage>176</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тонеев Е.А., Чигирёва И.Б., Шагдалеев Р.Ф., Фирстов А.А., Уренева Р.В., Павлов М.О., Мартынова Е.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Тонеев Е.А., Чигирёва И.Б., Шагдалеев Р.Ф., Фирстов А.А., Уренева Р.В., Павлов М.О., Мартынова Е.В.</copyright-holder><copyright-holder xml:lang="en">Toneev E.A., Chigireva I.B., Shagdaleev R.F., Firstov A.A., Ureneva R.V., Pavlov M.O., Martynova E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9271">https://www.med-sovet.pro/jour/article/view/9271</self-uri><abstract><sec><title>Введение</title><p>Введение. MALT-лимфома является редким гистологическим типом злокачественного заболевания легкого, которое развивается из лимфоидной ткани. Данный вид лимфом относится к неходжкинским лимфомам. Учитывая отсутствие единого принятого решения по лечению пациентов с MALT-лимфомой легкого, представлено собственное наблюдение по лечению данного заболевания. Каждое наблюдение является важным для дальнейшего принятия единой тактики лечения.</p></sec><sec><title>Цель</title><p>Цель. Продемонстрировать эффективность комплексного лечения двух пациентов с MALT-лимфомой легкого.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В работе представлено 2 клинических случая успешного лечения пациентов с MALT-лимфомой  в Областном клиническом онкологическом диспансере г. Ульяновска. Представлены собственные наблюдения по лечению таких пациентов и описаны схемы использованного лечения. Одному из пациентов была проведена пункция опухоли, которая оказалась безрезультативной. Учитывая неспецифичность клинической картины и обнаруженное по результатам КТ в правом легком объемное образование с неустановленным гистогенезом, а также поражение средостения, определены показания к хирургическому вмешательству для морфологической диагностики образования в легком. В обоих случаях таргетная поддержка ритуксимабом включена в схему лечения. В одном случае выполнено 5 курсов по схеме R-B без прогрессирования, в другом – пациенту планируется проведение таргетной терапии на следующем этапе после полного курса полихимиотерапии.</p></sec><sec><title>Выводы</title><p>Выводы. МАLТ-лимфома представляет собой редкую нозологическую форму. Наиболее оптимальным методом лечения может быть выбран комбинированный, который включает в себя применение хирургического лечения, полихимиотерапии и в последующем таргетной терапии. Хорошие результаты показывает применение R-B полихимиотерапии в лечении MALT-лимфом.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. MALT lymphoma is a rare histological type of malignant lung disease that develops from lymphoid tissue. This type of lymphoma belongs to the non-Hodgkin lymphomas. Given the lack of a standardized treatment protocol for patients with pulmonary MALT lymphoma, this study presents a case observation of the treatment of this disease. Each case observation is crucial for establishing a unified treatment strategy.</p></sec><sec><title>Aim</title><p>Aim. To demonstrate the effectiveness of comprehensive treatment in two patients with pulmonary MALT lymphoma.</p></sec><sec><title>Methods</title><p>Methods. This study presents two clinical cases of successful treatment of patients with MALT lymphoma at the regional clinical oncological dispensary in Ulyanovsk. The authors present their observations and describe the treatment regimens used. One patient underwent a tumor biopsy, which was inconclusive. Given the non-specific clinical presentation and the CT findings of a mass in the right lung with an undetermined histogenesis, as well as mediastinal involvement, surgical intervention was indicated for the morphological diagnosis of the lung mass. In both cases, targeted support with Rituximab was included in the treatment regimen. One case involved five courses of R-B therapy without progression, while in the other case, targeted therapy is planned as the next step after polychemotherapy.</p></sec><sec><title>Conclusions</title><p>Conclusions. MALT lymphoma is a rare nosological form. According to the authors, the most optimal treatment method is a combined approach, which includes surgical treatment, polychemotherapy, and subsequent targeted therapy.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>MALT-лимфома</kwd><kwd>лобэктомия</kwd><kwd>комбинированное лечение</kwd><kwd>ритуксимаб</kwd><kwd>полихимиотерапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>MALT lymphoma</kwd><kwd>lobectomy</kwd><kwd>combined treatment</kwd><kwd>rituximab</kwd><kwd>polychemotherapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Тонеев ЕА, Мартынов АА, Чарышкин АЛ, Базаров ДВ, Лазаревский ММ. Место хирургии в комбинированном лечении MALT-лимфомы легкого. Ульяновский медико-биологический журнал. 2018;3:87–93. https://doi.org/10.23648/UMBJ.2018.31.17219.</mixed-citation><mixed-citation xml:lang="en">Toneev EA, Martynov AA, Charyshkin AL, Bazarov DV, Lazarevskiy MM. Surgery in combined treatment of pulmonary malt-lymphoma. Ulyanovsk Medico-Biological Journal. 2018;3:87–93. (In Russ.) https://doi.org/10.23648/UMBJ.2018.31.17219.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wise LM, Arkfeld DG. A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review. Clin Rheumatol. 2020;39(4):1357–1362. https://doi.org/10.1007/s10067-019-04886-7.</mixed-citation><mixed-citation xml:lang="en">Wise LM, Arkfeld DG. A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review. Clin Rheumatol. 2020;39(4):1357–1362. https://doi.org/10.1007/s10067-019-04886-7.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Guo Z, Hu L, Chen Q, Hu J, Liu J, Hu W. Synchronous pulmonary MALT lymphoma and squamous cell lung cancer: a case report. World J Surg Oncol. 2023;21(1):182. https://doi.org/10.1186/s12957-023-03069-8.</mixed-citation><mixed-citation xml:lang="en">Guo Z, Hu L, Chen Q, Hu J, Liu J, Hu W. Synchronous pulmonary MALT lymphoma and squamous cell lung cancer: a case report. World J Surg Oncol. 2023;21(1):182.   https://doi.org/10.1186/s12957-023-03069-8.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Фролова ИГ, Веснина ВО, Величко СА, Гольдберг АВ, Попова МВ, Табакаев СА и др. MALT-лимфома с поражением лёгких, плевры и внутригрудных лимфатических узлов: клиническое наблюдение. Онкологический журнал: лучевая диагностика, лучевая терапия. 2018;1(4):92–100. Режим доступа: https://www.oncoradjournal.ru/jour/article/view/85/85.</mixed-citation><mixed-citation xml:lang="en">Frolova IG, Vesnina VO, Velichko SA, Goldberg AV, Popova MV, Tabakaev SA et al. MALT-Lymphoma with Impairment of Lung, Pleura and Mediastinum Lymph Nodes: Clinical Observation. Journal of Oncology: Diagnostic Radiology and Radiotherapy. 2018;1(4):92–100. (In Russ.) Available at: https://www.oncoradjournal.ru/jour/article/view/85/85.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Le Y, Zhu H, Ye C, Lin J, Wang N, Yang T. CT radiomics analysis discriminates pulmonary lesions in patients with pulmonary MALT lymphoma and nonpulmonary MALT lymphoma. Methods. 2024;224:54–62. https://doi.org/10.1016/j.ymeth.2024.02.003.</mixed-citation><mixed-citation xml:lang="en">Le Y, Zhu H, Ye C, Lin J, Wang N, Yang T. CT radiomics analysis discriminates pulmonary lesions in patients with pulmonary MALT lymphoma and nonpulmonary MALT lymphoma. Methods. 2024;224:54–62. https://doi.org/10.1016/j.ymeth.2024.02.003.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kou L, Huan NC, Nyanti LE, Chin JS, Mohamad NB, Ramarmuty HY. Pulmonary extra-nodal mucosa-associated lymphoid tissue (MALT) lymphoma: A rare cause of persistent lung consolidation. Respirol Case Rep. 2023;11(8):e01197. https://doi.org/10.1002/rcr2.1197.</mixed-citation><mixed-citation xml:lang="en">Kou L, Huan NC, Nyanti LE, Chin JS, Mohamad NB, Ramarmuty HY. Pulmonary extra-nodal  mucosa-associated  lymphoid  tissue  (MALT)  lymphoma: A rare cause of persistent lung consolidation. Respirol Case Rep. 2023;11(8):e01197.  https://doi.org/10.1002/rcr2.1197.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dong C, Xia P, Qiu W, Dai Z, Wang Z. Evaluation of CT features for differentiating consolidation pattern of pulmonary MALT lymphoma from pneumonic-type lung adenocarcinoma. Front Oncol. 2023;13:1234291. https://doi.org/10.3389/fonc.2023.1234291.</mixed-citation><mixed-citation xml:lang="en">Dong C, Xia P, Qiu W, Dai Z, Wang Z. Evaluation of CT features for differentiating consolidation pattern of pulmonary MALT lymphoma from pneumonic-type lung adenocarcinoma. Front Oncol. 2023;13:1234291. https://doi.org/10.3389/fonc.2023.1234291.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983;52(8):1410–1416. https://doi.org/10.1002/1097-0142(19831015)52:8&lt;1410::aidcncr2820520813&gt;3.0.co;2-3.</mixed-citation><mixed-citation xml:lang="en">Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983;52(8):1410–1416. https://doi.org/10.1002/1097-0142(19831015)52:8&lt;1410::aidcncr2820520813&gt;3.0.co;2-3.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101(7):2489–2495. https://doi.org/10.1182/blood-2002-04-1279.</mixed-citation><mixed-citation xml:lang="en">Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid  tissue. Blood. 2003;101(7):2489–2495. https://doi.org/10.1182/ blood-2002-04-1279.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Di Rocco A, Petrucci L, Assanto GM, Martelli M, Pulsoni A. Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment. Cancers. 2022;14(7):1742. https://doi.org/10.3390/cancers14071742.</mixed-citation><mixed-citation xml:lang="en">Di Rocco A, Petrucci L, Assanto GM, Martelli M, Pulsoni A. Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment. Cancers. 2022;14(7):1742.  https://doi.org/10.3390/cancers14071742.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol. 1998;16(8):2780–2795. https://doi.org/10.1200/JCO.1998.16.8.2780.</mixed-citation><mixed-citation xml:lang="en">Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. NonHodgkin’s Lymphoma Classification Project. J Clin Oncol. 1998;16(8):2780–2795.  https://doi.org/10.1200/JCO.1998.16.8.2780.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Borie R, Antoine M, Cadranel J, Wislez M. Pulmonary malt lymphoma. Bull Cancer. 2014;101(2):195–202. https://doi.org/10.1684/bdc.2014.1885.</mixed-citation><mixed-citation xml:lang="en">Borie R, Antoine M, Cadranel J, Wislez M. Pulmonary malt lymphoma. Bull Cancer. 2014;101(2):195–202. https://doi.org/10.1684/bdc.2014.1885.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sehn LH, Salles G. Diffuse Large B-Cell Lymphoma. N Engl J Med. 2021;384(9):842–858. https://doi.org/10.1056/NEJMra2027612.</mixed-citation><mixed-citation xml:lang="en">Sehn LH, Salles G. Diffuse Large B-Cell Lymphoma. N Engl J Med. 2021;384(9):842–858.   https://doi.org/10.1056/NEJMra2027612.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H et al. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. J Chemother. 2015;27(2):99–105. https://doi.org/10.1179/1973947814Y.0000000219.</mixed-citation><mixed-citation xml:lang="en">Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H et al. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. J Chemother. 2015;27(2):99–105. https://doi.org/10.1179/1973947814Y.0000000219.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Starr AG, Caimi PF, Fu P, Massoud MR, Meyerson H, Hsi ED et al. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era. Br J Haematol. 2016;175(2):275–280. https://doi.org/10.1111/bjh.14228.</mixed-citation><mixed-citation xml:lang="en">Starr AG, Caimi PF, Fu P, Massoud MR, Meyerson H, Hsi ED et al. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era. Br J Haematol. 2016;175(2):275–280.   https://doi.org/10.1111/bjh.14228.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang CS, Yang XR, Ding W, Lu XY, Shen L, Zhao YF. Pulmonary mucosaassociated lymphoid tissue lymphoma concurrent with lung squamous cell carcinoma: a case report and literature review. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(12):1071–1076. https://doi.org/10.3760/cma.j.cn11214720200729-00859.</mixed-citation><mixed-citation xml:lang="en">Zhang CS, Yang XR, Ding W, Lu XY, Shen L, Zhao YF. Pulmonary mucosaassociated lymphoid tissue lymphoma concurrent with lung squamous  cell carcinoma: a case report and literature review. Zhonghua Jie He He Hu Xi  Za  Zhi. 2020;43(12):1071–1076. https://doi.org/10.3760/cma.j.cn11214720200729-00859.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Becnel MR, Nastoupil LJ, Samaniego F, Davis RE, You MJ, Green M et al. Lenalidomide plus rituximab (R2) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial. Br J Haematol. 2019;185(5):874–882. https://doi.org/10.1111/bjh.15843.</mixed-citation><mixed-citation xml:lang="en">Becnel MR, Nastoupil LJ, Samaniego F, Davis RE, You MJ, Green M et al. Lenalidomide plus rituximab (R2) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial. Br J Haematol. 2019;185(5):874–882. https://doi.org/10.1111/bjh.15843.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa E, Nakamura M, Satou A, Shimada K, Nakamura S. Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era. Cancers. 2022;14(2):446. https://doi.org/10.3390/cancers14020446.</mixed-citation><mixed-citation xml:lang="en">Ishikawa E, Nakamura M, Satou A, Shimada K, Nakamura S. MucosaAssociated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era. Cancers. 2022;14(2):446. https://doi.org/10.3390/cancers14020446.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Filip PV, Cuciureanu D, Diaconu LS, Vladareanu AM, Pop CS. MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life. 2018;11(3):187–193. https://doi.org/10.25122/jml-2018-0035.</mixed-citation><mixed-citation xml:lang="en">Filip PV, Cuciureanu D, Diaconu LS, Vladareanu AM, Pop CS. MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life. 2018;11(3):187–193. https://doi.org/10.25122/jml-2018-0035.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, He Z, Zhu Z, Luo R. Primary pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: a case report and literature review. Am J Transl Res. 2022;14(12):9072–9077. Available at: https://pubmed.ncbi.nlm.nih.gov/36628239/.</mixed-citation><mixed-citation xml:lang="en">Wang Y, He Z, Zhu Z, Luo R. Primary pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: a case report and literature review. Am J Transl Res. 2022;14(12):9072–9077. Available  at:  https://pubmed.ncbi.nlm.nih.gov/36628239/.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
